Abstract
PURPOSE: 
To
 compare the effectiveness of 6.0 to 8.0 mm-wide diameter implants, 
placed immediately after tooth extraction, with conventional 4.0 or 5.0 
mm diameter implants placed in a preserved socket after a 4-month period
 of healing in the molar region.
MATERIALS AND METHODS: 
Just
 after extraction of one or two molar teeth, and with no vertical loss 
of the buccal bone in relation to the palatal wall, 100 patients 
requiring immediate post-extractive implants were randomly allocated to 
immediate placement of one or two 6.0 to 8.0 mm-wide diameter implants 
(immediate group; 50 patients) or for socket preservation using a 
porcine bone substitute covered by a resorbable collagen barrier 
(delayed group; 50 patients), according to a parallel group design in 
one centre. Bone-to-implant gaps were filled with autogenous bone 
retrieved with a trephine drill used to prepare the implant sites for 
the immediate wide diameter post-extractive implants. Four months after 
socket preservation, one to two 4.0 or 5.0 mm-wide delayed implants were
 placed. Implants were loaded 4 months after placement with fixed 
provisional restorations in acrylic, and replaced after 4 months by 
fixed, definitive, metal-ceramic restorations. Patients were followed to
 1 year after loading. Outcome measures were: implant failures, 
complications, aesthetics assessed using the pink esthetic score (PES), 
peri-implant marginal bone level changes, patient satisfaction, number 
of appointments and surgical interventions recorded, when possible, by 
blinded assessors.
RESULTS: 
Three
 patients dropped out 1 year after loading from the immediate group vs 
six from the delayed group. Five implants out of 47 failed in the 
immediate group (10.6%) vs two out 44 (4.6%) in the delayed group, the 
difference being not statistically significant (difference in proportion
 = 6.0%, 95% CI: -8.8% to 20.8%, P = 0.436). In the immediate group 10 
patients were affected by 10 complications, while in the delayed group 
four patients were affected by four complications. The difference was 
not statistically significant (difference in proportion = 12%, 95% CI: 
-2% to 26%, P = 0.084). At delivery of the definitive prostheses, 4 
months after loading, the mean total PES score was 9.65 ± 1.62 and 10.44
 ± 1.47 in the immediate and delayed groups, respectively. At 1 year 
after loading, the mean total PES score was 9.71 ± 2.71 and 10.86 ± 1.37
 in the immediate and delayed groups, respectively. The Total PES score 
was statistically significantly better at delayed implants both at 4 
months (mean difference = 0.79; 95% CI: 0.05 to 1.53; P = 0.03) and at 1
 year (mean difference = 1.15; 95% CI: 0.13 to 2.17; P = 0.02). Marginal
 bone levels at implant insertion (after bone grafting) were 0.04 mm for
 immediate and 0.11 mm for delayed implants, which was statistically 
significantly different (mean difference = 0.07; 95% CI: 0.02 to 0.12; P
 < 0.0001). One year after loading, patients in the immediate group 
lost on average 1.06 mm and those from the delayed group 0.63 mm, the 
difference being statistically significant (mean difference = 0.43 mm; 
95% CI: 0.15 to 0.61; P < 0.0001). All patients were fully or 
partially satisfied both for function and aesthetics, and would undergo 
the same procedure again both at 4 months and 1 year after loading. 
Patients from the immediate group required on average 7.48 ± 1.45 visits
 to the clinician and 2.14 ± 0.49 surgical interventions and to have 
their definitive prostheses delivered vs 10.30 ± 0.99 visits and 3.08 ± 
0.40 surgical interventions for the delayed group, the difference being 
statistically significant (P < 0.001 for visits, and P < 0.001 for
 surgical interventions).
CONCLUSIONS: 
Preliminary
 1 year follow-up data suggest that immediate placement of 6.0 to 8.0 mm
 wide diameter implants in molar extraction sockets yielded inferior 
aesthetic outcomes than ridge preservation and delayed placement of 
conventional 4.0 to 5.0 mm diameter implants. Conflict of interest 
statement: This trial was partially funded by the manufacturer of the 
implants evaluated in this investigation (MegaGen Implant Co, Gyeongbuk,
 South Korea). However, data belonged to the authors and in no way did 
the manufacturer interfere with the conduct of the trial or the 
publication of its results.
 
 
Comments